{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T17:13:31Z","timestamp":1789146811334,"version":"build-2803163510"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008871","name":"Yunnan Provincial Science and Technology Department","doi-asserted-by":"publisher","award":["202401AZ070001-097"],"award-info":[{"award-number":["202401AZ070001-097"]}],"id":[{"id":"10.13039\/501100008871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82460428"],"award-info":[{"award-number":["82460428"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82360523"],"award-info":[{"award-number":["82360523"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82060423"],"award-info":[{"award-number":["82060423"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003996","name":"Kunming Medical University","doi-asserted-by":"publisher","award":["202510678032"],"award-info":[{"award-number":["202510678032"]}],"id":[{"id":"10.13039\/501100003996","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003996","name":"Kunming Medical University","doi-asserted-by":"publisher","award":["202510678031"],"award-info":[{"award-number":["202510678031"]}],"id":[{"id":"10.13039\/501100003996","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003996","name":"Kunming Medical University","doi-asserted-by":"publisher","award":["202510678033"],"award-info":[{"award-number":["202510678033"]}],"id":[{"id":"10.13039\/501100003996","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003996","name":"Kunming Medical University","doi-asserted-by":"publisher","award":["202510678030"],"award-info":[{"award-number":["202510678030"]}],"id":[{"id":"10.13039\/501100003996","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003996","name":"Kunming Medical University","doi-asserted-by":"publisher","award":["2024XKT DTS11"],"award-info":[{"award-number":["2024XKT DTS11"]}],"id":[{"id":"10.13039\/501100003996","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003996","name":"Kunming Medical University","doi-asserted-by":"publisher","award":["CXTD202210"],"award-info":[{"award-number":["CXTD202210"]}],"id":[{"id":"10.13039\/501100003996","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lungcancerjournal.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.lungcan.2026.109599","type":"journal-article","created":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T15:29:50Z","timestamp":1788190190000},"page":"109599","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["IL20RB drives non-small cell lung cancer progression and immune evasion via K267\u2011dependent activation of JAK2 phosphorylation and STAT3 signaling"],"prefix":"10.1016","volume":"220","author":[{"given":"Yanghao","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weizhou","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hengrui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajie","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirong","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyu","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulin","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayi","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongwen","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Bian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lungcan.2026.109599_b0005","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.ccell.2023.12.021","article-title":"Cancer-associated fibroblast phenotypes are associated with patient outcome in non-small cell lung cancer","volume":"42","author":"Cords","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.lungcan.2026.109599_b0010","article-title":"Identification of disulfidptosis-related subgroups and prognostic signatures in lung adenocarcinoma using machine learning and experimental validation","volume":"14","author":"Wang","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lungcan.2026.109599_b0015","article-title":"Role of the SOX family in non\u2011small cell lung cancer: Molecular mechanisms and therapeutic implications (Review)","volume":"55","author":"Wang","year":"2026","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.lungcan.2026.109599_b0020","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1002\/cac2.12197","article-title":"Cancer incidence, mortality, and burden in China: a time-trend analysis and comparison with the United States and United Kingdom based on the global epidemiological data released in 2020","volume":"41","author":"Qiu","year":"2021","journal-title":"Cancer Commun. (London, England)"},{"key":"10.1016\/j.lungcan.2026.109599_b0025","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1200\/JCO.2017.74.4771","article-title":"Sequencing of postoperative radiotherapy and chemotherapy for locally advanced or incompletely resected non-small-cell lung cancer","volume":"36","author":"Francis","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lungcan.2026.109599_b0030","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0140-6736(24)01029-8","article-title":"New promises and challenges in the treatment of advanced non-small-cell lung cancer","volume":"404","author":"Meyer","year":"2024","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.lungcan.2026.109599_b0035","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1016\/j.cell.2025.03.018","article-title":"A single-cell atlas reveals immune heterogeneity in anti-PD-1-treated non-small cell lung cancer","volume":"188","author":"Liu","year":"2025","journal-title":"Cell"},{"key":"10.1016\/j.lungcan.2026.109599_b0040","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s12943-025-02276-z","article-title":"IL-4 mediated TAP2 downregulation is a dominant and reversible mechanism of immune evasion and immunotherapy resistance in non-small cell lung cancer","volume":"24","author":"Ranjan","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.lungcan.2026.109599_b0045","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/s41571-025-01021-1","article-title":"Tumour and microenvironment crosstalk in NSCLC progression and response to therapy","volume":"22","author":"Rahal","year":"2025","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.lungcan.2026.109599_b0050","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/s41571-025-01029-7","article-title":"Rechallenge with immune-checkpoint inhibitors in patients with advanced-stage lung cancer","volume":"22","author":"Tang","year":"2025","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.lungcan.2026.109599_b0055","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23137222","article-title":"Targeted therapy and immunotherapy in early-stage non-small cell lung cancer: current evidence and ongoing trials","volume":"23","author":"de Scordilli","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lungcan.2026.109599_b0060","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1038\/s41591-021-01450-2","article-title":"Toward personalized treatment approaches for non-small-cell lung cancer","volume":"27","author":"Wang","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.lungcan.2026.109599_b0065","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/s41586-024-08439-0","article-title":"Immune evasion through mitochondrial transfer in the tumour microenvironment","volume":"638","author":"Ikeda","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.lungcan.2026.109599_b0070","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.jare.2024.09.005","article-title":"Serum taurine affects lung cancer progression by regulating tumor immune escape mediated by the immune microenvironment","volume":"73","author":"Liang","year":"2025","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.lungcan.2026.109599_b0075","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2025.1530541","article-title":"Adoptive cell therapy against tumor immune evasion: mechanisms, innovations, and future directions","volume":"15","author":"Ruan","year":"2025","journal-title":"Front. Oncol."},{"key":"10.1016\/j.lungcan.2026.109599_b0080","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-000966","article-title":"T-cell agonists in cancer immunotherapy","volume":"8","author":"Choi","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.lungcan.2026.109599_b0085","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.trecan.2022.06.008","article-title":"Therapeutic targeting of regulatory T cells in cancer","volume":"8","author":"Shan","year":"2022","journal-title":"Trends Cancer"},{"key":"10.1016\/j.lungcan.2026.109599_b0090","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1126\/science.aar6711","article-title":"CAR T cell immunotherapy for human cancer","volume":"359","author":"June","year":"2018","journal-title":"Science (New York N.Y.)"},{"key":"10.1016\/j.lungcan.2026.109599_b0095","article-title":"Interferon-\u03b3-stimulated antigen-presenting cancer-associated fibroblasts hinder neoadjuvant chemoimmunotherapy efficacy in lung cancer","volume":"6","author":"Cao","year":"2025","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.lungcan.2026.109599_b0100","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41571-018-0142-8","article-title":"Cancer immunoediting and resistance to T cell-based immunotherapy","volume":"16","author":"O'Donnell","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.lungcan.2026.109599_b0105","doi-asserted-by":"crossref","first-page":"8673","DOI":"10.1038\/s41467-025-63696-5","article-title":"Tumor immune dynamics and long-term clinical outcome of stage IIIA NSCLC patients treated with neoadjuvant chemoimmunotherapy","volume":"16","author":"Schmid","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.lungcan.2026.109599_b0110","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1038\/s41591-024-03240-y","article-title":"Neoantigen immunogenicity landscapes and evolution of tumor ecosystems during immunotherapy with nivolumab","volume":"30","author":"Alban","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.lungcan.2026.109599_b0115","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/imr.12772","article-title":"T cell receptor-based cancer immunotherapy: Emerging efficacy and pathways of resistance","volume":"290","author":"Chandran","year":"2019","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.lungcan.2026.109599_b0120","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1158\/0008-5472.CAN-14-2538","article-title":"Cancer immunotherapy and breaking immune tolerance: new approaches to an old challenge","volume":"75","author":"Makkouk","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.lungcan.2026.109599_b0125","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/1756-8722-6-74","article-title":"The role of PD-1 and PD-L1 in T-cell immune suppression in patients with hematological malignancies","volume":"6","author":"Shi","year":"2013","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.lungcan.2026.109599_b0130","article-title":"CircCFL1 promotes TNBC stemness and immunoescape via deacetylation-mediated c-myc deubiquitylation to facilitate mutant TP53 Transcription","volume":"11","author":"Wang","year":"2024","journal-title":"Adv. Sci. (Weinheim Baden-Wurttemberg, Germany)"},{"key":"10.1016\/j.lungcan.2026.109599_b0135","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/s41568-023-00560-y","article-title":"Dynamics and specificities of T cells in cancer immunotherapy","volume":"23","author":"Oliveira","year":"2023","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.lungcan.2026.109599_b0140","article-title":"Controlling T cell-tumor cell interaction with a biomimetic physical barrier for cancer immunotherapy","volume":"122","author":"Zhang","year":"2025","journal-title":"PNAS"},{"key":"10.1016\/j.lungcan.2026.109599_b0145","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1293\/tox.2019-0017","article-title":"Overexpression of interleukin-20 receptor subunit beta (IL20RB) correlates with cell proliferation, invasion and migration enhancement and poor prognosis in papillary renal cell carcinoma","volume":"32","author":"Cui","year":"2019","journal-title":"J. Toxicol. Pathol."},{"key":"10.1016\/j.lungcan.2026.109599_b0150","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/nri3766","article-title":"The IL-20 subfamily of cytokines\u2013from host defence to tissue homeostasis","volume":"14","author":"Rutz","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.lungcan.2026.109599_b0155","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.ebiom.2018.10.031","article-title":"Production of Interleukin-20 cytokines limits bacterial clearance and lung inflammation during infection by Streptococcus pneumoniae","volume":"37","author":"Madouri","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/j.lungcan.2026.109599_b0160","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12863-022-01076-4","article-title":"Interleukin 20 receptor subunit beta (IL20RB) predicts poor prognosis and regulates immune cell infiltration in clear cell renal cell carcinoma","volume":"23","author":"Zhang","year":"2022","journal-title":"BMC Genomic Data"},{"key":"10.1016\/j.lungcan.2026.109599_b0165","article-title":"IL22RA1\/JAK\/STAT signaling acts as a cancer target through pan-cancer analysis","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lungcan.2026.109599_b0170","doi-asserted-by":"crossref","first-page":"8","DOI":"10.21037\/tcr-2025-2054","article-title":"IL20RB as a prognostic and immune-related biomarker in lung cancer: association with immune infiltration, tumor progression, and potential therapeutic targeting","volume":"15","author":"Li","year":"2026","journal-title":"Transl. Cancer Res."},{"key":"10.1016\/j.lungcan.2026.109599_b0175","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/9443407","article-title":"Identification of IL20RB as a novel prognostic and therapeutic biomarker in clear cell renal cell carcinoma","volume":"2022","author":"Guo","year":"2022","journal-title":"Dis. Markers"},{"key":"10.1016\/j.lungcan.2026.109599_b0180","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","article-title":"Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response","volume":"24","author":"Jiang","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.lungcan.2026.109599_b0185","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1016\/j.ejca.2011.04.012","article-title":"IL-20 is epigenetically regulated in NSCLC and down regulates the expression of VEGF","volume":"47","author":"Baird","year":"2011","journal-title":"Eur. J. Cancer (Oxford, England : 1990)"},{"key":"10.1016\/j.lungcan.2026.109599_b0190","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13143513","article-title":"Expression of retroelements in cervical cancer and their interplay with HPV infection and host gene expression","volume":"13","author":"Curty","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.lungcan.2026.109599_b0195","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.immuni.2022.12.006","article-title":"Bispecific PD1-IL2v and anti-PD-L1 break tumor immunity resistance by enhancing stem-like tumor-reactive CD8(+) Tcells and reprogramming macrophages","volume":"56","author":"Tichet","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.lungcan.2026.109599_b0200","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.immuni.2018.03.014","article-title":"Regulation and function of the PD-L1 checkpoint","volume":"48","author":"Sun","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.lungcan.2026.109599_b0205","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/s41423-020-00565-9","article-title":"Tumor-infiltrating lymphocytes in the immunotherapy era","volume":"18","author":"Paijens","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.lungcan.2026.109599_b0210","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/s41568-022-00466-1","article-title":"Tumour-infiltrating B cells: immunological mechanisms, clinical impact and therapeutic opportunities","volume":"22","author":"Laumont","year":"2022","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.lungcan.2026.109599_b0215","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ccell.2020.11.005","article-title":"Immunogenic chemotherapy enhances recruitment of CAR-T cells to lung tumors and improves antitumor efficacy when combined with checkpoint blockade","volume":"39","author":"Srivastava","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.lungcan.2026.109599_b0220","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s00262-020-02506-x","article-title":"Tumor mutational load, CD8(+) T cells, expression of PD-L1 and HLA class I to guide immunotherapy decisions in NSCLC patients","volume":"69","author":"Hurkmans","year":"2020","journal-title":"Cancer Immunol. Immunother. CII"},{"key":"10.1016\/j.lungcan.2026.109599_b0225","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s13046-016-0439-3","article-title":"Trends and advances in tumor immunology and lung cancer immunotherapy","volume":"35","author":"Aldarouish","year":"2016","journal-title":"J. Experim. Clin. Cancer Res.: CR"},{"key":"10.1016\/j.lungcan.2026.109599_b0230","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.critrevonc.2019.08.009","article-title":"The clinical significance of soluble PD-1 and PD-L1 in lung cancer","volume":"143","author":"Abu Hejleh","year":"2019","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.lungcan.2026.109599_b0235","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ccell.2016.02.004","article-title":"Facilitating T cell infiltration in tumor microenvironment overcomes resistance to PD-L1 blockade","volume":"29","author":"Tang","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.lungcan.2026.109599_b0240","doi-asserted-by":"crossref","first-page":"4703","DOI":"10.1038\/s41467-023-40398-4","article-title":"Combined PD-L1\/TGF\u03b2 blockade allows expansion and differentiation of stem cell-like CD8 T cells in immune excluded tumors","volume":"14","author":"Castiglioni","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.lungcan.2026.109599_b0245","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/PPO.0000000000000303","article-title":"Mechanisms of resistance to PD-1 and PD-L1 blockade","volume":"24","author":"Nowicki","year":"2018","journal-title":"Cancer J. (Sudbury, Mass.)"},{"key":"10.1016\/j.lungcan.2026.109599_b0250","article-title":"Resistance to immune checkpoint inhibitors in non-small cell lung cancer: biomarkers and therapeutic strategies","volume":"12","author":"Walsh","year":"2020","journal-title":"Therap. Adv. Med. Oncol."},{"key":"10.1016\/j.lungcan.2026.109599_b0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106210","article-title":"The role of JAK\/STAT signaling pathway and its inhibitors in diseases","volume":"80","author":"Xin","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.lungcan.2026.109599_b0260","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1146\/annurev-med-051113-024537","article-title":"The JAK-STAT pathway: impact on human disease and therapeutic intervention","volume":"66","author":"O'Shea","year":"2015","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.lungcan.2026.109599_b0265","doi-asserted-by":"crossref","first-page":"13949","DOI":"10.1111\/jcmm.16003","article-title":"IGF2BP3 facilitates cell proliferation and tumorigenesis via modulation of JAK\/STAT signalling pathway in human bladder cancer","volume":"24","author":"Huang","year":"2020","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.lungcan.2026.109599_b0270","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1186\/s12935-021-02304-0","article-title":"YTHDC1-mediated VPS25 regulates cell cycle by targeting JAK-STAT signaling in human glioma cells","volume":"21","author":"Zhu","year":"2021","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.lungcan.2026.109599_b0275","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1038\/s41467-022-28523-1","article-title":"T-cell dysfunction in the glioblastoma microenvironment is mediated by myeloid cells releasing interleukin-10","volume":"13","author":"Ravi","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.lungcan.2026.109599_b0280","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.semcancer.2019.10.002","article-title":"The potential and controversy of targeting STAT family members in cancer","volume":"60","author":"Verhoeven","year":"2020","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.lungcan.2026.109599_b0285","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.pdpdt.2016.01.008","article-title":"ALA-PDT inhibits proliferation and promotes apoptosis of SCC cells through STAT3 signal pathway","volume":"14","author":"Qiao","year":"2016","journal-title":"Photodiagn. Photodyn. Ther."},{"key":"10.1016\/j.lungcan.2026.109599_b0290","doi-asserted-by":"crossref","first-page":"E5716","DOI":"10.1073\/pnas.1411248112","article-title":"STAT3 promotes survival of mutant photoreceptors in inherited photoreceptor degeneration models","volume":"111","author":"Jiang","year":"2014","journal-title":"PNAS"},{"key":"10.1016\/j.lungcan.2026.109599_b0295","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1038\/s41591-020-0926-0","article-title":"A single-cell landscape of high-grade serous ovarian cancer","volume":"26","author":"Izar","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.lungcan.2026.109599_b0300","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24044002","article-title":"Crosstalk of inflammatory cytokines within the breast tumor microenvironment","volume":"24","author":"Habanjar","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lungcan.2026.109599_b0305","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23031310","article-title":"The role of podoplanin in skin diseases","volume":"23","author":"Asai","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lungcan.2026.109599_b0310","first-page":"150","article-title":"Mitochondrial damage and biogenesis in acetaminophen-induced liver injury","volume":"3","author":"Jaeschke","year":"2019","journal-title":"Liver Res. (Beijing, China)"},{"key":"10.1016\/j.lungcan.2026.109599_b0315","doi-asserted-by":"crossref","DOI":"10.1242\/dev.201548","article-title":"Separation of transcriptional repressor and activator functions in Drosophila HDAC3","volume":"150","author":"Tang","year":"2023","journal-title":"Development"},{"key":"10.1016\/j.lungcan.2026.109599_b0320","doi-asserted-by":"crossref","first-page":"485","DOI":"10.3892\/ijmm.2015.2254","article-title":"Acetaminophen induces JNK\/p38 signaling and activates the caspase-9-3-dependent cell death pathway in human mesenchymal stem cells","volume":"36","author":"Yiang","year":"2015","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.lungcan.2026.109599_b0325","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-010612","article-title":"Cell-intrinsic PD-L1 signaling drives immunosuppression by myeloid-derived suppressor cells through IL-6\/Jak\/Stat3 in PD-L1-high lung cancer","volume":"13","author":"Jeong","year":"2025","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.lungcan.2026.109599_b0330","doi-asserted-by":"crossref","first-page":"5365","DOI":"10.7150\/thno.58390","article-title":"Turning cold tumors into hot tumors by improving T-cell infiltration","volume":"11","author":"Liu","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.lungcan.2026.109599_b0335","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.annonc.2022.05.010","article-title":"Impact of acetaminophen on the efficacy of immunotherapy in cancer patients","volume":"33","author":"Bessede","year":"2022","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.lungcan.2026.109599_b0340","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1682686","article-title":"Acetaminophen use and prognosis in cancer patients treated with immune checkpoint inhibitors: evidence from a meta-analysis","volume":"16","author":"Lin","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lungcan.2026.109599_b0345","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1097\/FPC.0000000000000150","article-title":"PharmGKB summary: pathways of acetaminophen metabolism at the therapeutic versus toxic doses","volume":"25","author":"Mazaleuskaya","year":"2015","journal-title":"Pharmacogenet. Genomics"},{"key":"10.1016\/j.lungcan.2026.109599_b0350","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3389\/fonc.2013.00193","article-title":"Strategies to increase drug penetration in solid tumors","volume":"3","author":"Choi","year":"2013","journal-title":"Front. Oncol."},{"key":"10.1016\/j.lungcan.2026.109599_b0355","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3390\/livers4010007","article-title":"High-dose acetaminophen as a treatment for cancer","volume":"4","author":"Wu","year":"2024","journal-title":"Livers"},{"key":"10.1016\/j.lungcan.2026.109599_b0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.02.056","article-title":"Advances in polymer nanomaterials targeting cGAS-STING pathway for enhanced cancer immunotherapy","volume":"381","author":"Peng","year":"2025","journal-title":"J. Control. Release"}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500226006604?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500226006604?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T16:55:18Z","timestamp":1789145718000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500226006604"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":72,"alternative-id":["S0169500226006604"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2026.109599","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IL20RB drives non-small cell lung cancer progression and immune evasion via K267\u2011dependent activation of JAK2 phosphorylation and STAT3 signaling","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2026.109599","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"109599"}}